Vera Therapeutics, Inc.

NasdaqGM:VERA Stock Report

Market Cap: US$2.4b

Vera Therapeutics Balance Sheet Health

Financial Health criteria checks 5/6

Vera Therapeutics has a total shareholder equity of $101.7M and total debt of $49.9M, which brings its debt-to-equity ratio to 49.1%. Its total assets and total liabilities are $175.5M and $73.9M respectively.

Key information

49.1%

Debt to equity ratio

US$49.88m

Debt

Interest coverage ration/a
CashUS$160.72m
EquityUS$101.69m
Total liabilitiesUS$73.86m
Total assetsUS$175.55m

Recent financial health updates

Recent updates

Vera Therapeutics: Soaring On IgAN Data, But Full Approval A Distant Prospect

Jan 25

Vera Therapeutics: Under The Radar IgAN Player Has Much To Prove

Sep 06

Vera Therapeutics GAAP EPS of -$0.55 beats by $0.17

Aug 10

Companies Like Vera Therapeutics (NASDAQ:VERA) Are In A Position To Invest In Growth

Feb 16
Companies Like Vera Therapeutics (NASDAQ:VERA) Are In A Position To Invest In Growth

Vera: Biotech With 3 Mid-Stage Programs With Potential For Success

Jan 19

Vera Therapeutics: Surprising Pivot To A Kidney Disease Drug Looks Like A Long Shot

Jan 07

We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth

Oct 25
We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth

Vera Therapeutics soars 16% on three new favorable view from analysts

Jun 08

Financial Position Analysis

Short Term Liabilities: VERA's short term assets ($172.0M) exceed its short term liabilities ($22.3M).

Long Term Liabilities: VERA's short term assets ($172.0M) exceed its long term liabilities ($51.6M).


Debt to Equity History and Analysis

Debt Level: VERA has more cash than its total debt.

Reducing Debt: Insufficient data to determine if VERA's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VERA has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: VERA has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 38.7% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.